| abstract |
The present invention relates to an isolated monoclonal antibody or an antigen-binding portion thereof, which includes a) binding to integrin Mac-1 and b) specifically suppressing the interaction between active Mac-1 and CD40L. And c) providing an isolated monoclonal antibody or an antigen-binding portion thereof, which does not induce outside-in signal transduction via the integrin. |